𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Angiogenesis, endothelial cell functions, and tumor cell growth in biodegradable and nonbiodegradable devices

✍ Scribed by Xia Zhao; Suzanne Kalliomäki; Xiangdong Wang; Jacob Kalliomäki; Roland Andersson


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
392 KB
Volume
74B
Category
Article
ISSN
1552-4973

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Development of tissue engineering creates multiple potentials for clinical treatment and scientific research. Biodegradable collagen matrices have been found to support simultaneous autotransplantation of hepatocytes after major liver resection. Dynamic angiogenesis in biodegradable devices (BDD) and nondegradable devices (NDD) transplanted into the renal subcapsule and subcutaneous tissue was measured by the distribution of radiolabeled red blood cells and serum albumin. The circulation, microvascular integrity, and capacities of endothelial cells (adhesion, proliferation, and migration) were investigated within 2 weeks after subcutaneous transplantation of both devices. Patterns of tumor cell growth in both devices were morphologically studied. After subcutaneous transplantation, significant angiogenesis was noted at 1 week in BDD implants and from 2 weeks and on in NDD implants, with an increase in implant blood and plasma volumes. Leakage index of radiolabeled albumin in NDD implants was significantly higher than in BDD implants, while the leakage index 2 weeks after BDD implant was similar to that in subcutaneous tissues. Adhesion, proliferation and migration rates of endothelial cells isolated from both devices were higher than from subcutaneous tissues. Endothelial proliferation and migration rates in BDD implants were significantly higher at 1 week, while in NDD at 2 weeks. Tumor cells migrated and grew on the top surface of NDD with a flattened shape, while growing within the BDD forming a round mass. Endothelial capacities, angiogenetic procedure, and biological and physical characteristics of the device contribute to patterns of tumor cell growth in the device. Biodegradable collagen matrix with three‐dimensional structure is suitable for simultaneous transplantation with cells without prevascularization. © 2005 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2005


📜 SIMILAR VOLUMES


Angiogenesis inhibitors overcome tumor i
✍ Arjan W. Griffioen; Cora A. Damen; Kevin H. Mayo; Annemarie F. Barendsz-Janson; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 154 KB

We report here that tumor angiogenesis-mediated endothelial cell (EC) anergy can be overcome by inhibitors of angiogenesis. We found previously that tumor growth, known to be dependent on angiogenesis, results in down-regulation of endothelial adhesion molecules and tumor EC anergy to inflammatory s

Resveratrol derivative-rich melinjo (Gne
✍ Kazuhiro Kunimasa; Toshiro Ohta; Hiroko Tani; Eishin Kato; Ryoji Eguchi; Kazuhik 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB

## Abstract Angiogenesis is a promising target for cancer prevention and treatment. This study aimed to determine the antiangiogenic effects of melinjo (__Gnetum gnemon__ L.) seed extract and its resveratrol derivative components, such as gnetin C (GC), gnetin L (GL), gnemonoside A (GMA), gnemonosi

MAZ51, an indolinone that inhibits endot
✍ Vladimir Kirkin; Wilko Thiele; Petra Baumann; Ralph Mazitschek; Katrin Rohde; Gu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 400 KB 👁 1 views

## Abstract We have recently described MAZ51, an indolinone that blocks the ligand‐induced autophosphorylation of VEGFR‐3, a receptor tyrosine kinase that plays a central role in the regulation of lymphangiogenesis. Here we show that MAZ51 is able to block the proliferation of VEGFR‐3‐expressing hu

Vascular endothelial growth factor expre
✍ Kimitoshi Inoue; Yuichi Ozeki; Toshiyuki Suganuma; Yoshiaki Sugiura; Susumu Tana 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB 👁 2 views

## Background: Angiogenesis is essential for solid tumor growth and metastasis. vascular endothelial growth factor (vegf), a recently identified growth factor with significant angiogenic properties, may be a major tumor angiogenesis regulator in vivo. conversely, there have been few studies of the

The effects of aging on tumor growth and
✍ May J. Reed; Nathan Karres; Daniel Eyman; Abigail Cruz; Rolf A. Brekken; Stephen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 479 KB

## Abstract It is generally accepted that histologically similar tumors grow more slowly, with less angiogenesis, in aged mice relative to young mice. We subcutaneously implanted TRAMP‐C2 tumor cells, a prostate cancer cell line not previously examined in aging, into syngeneic C57/Bl6 young (4 mont